|
The NUCRYST Pharmaceuticals' management team has a broad base of pharmaceutical and medical device management experience, including product development and launches of major pharmaceutical products and medical devices.
David Holtz -Carol Amelio - David C. McDowell
David Holtz
Interim President and Chief Executive Officer (CEO)
Chief Financial Officer (CFO)
Mr. Holtz joined NUCRYST in May 2008 as Vice President and CFO, and in January 2009 assumed the additional role of Interim President and CEO.
Before joining NUCRYST, Mr. Holtz served as a financial management consultant for various start-up companies, including Virium Pharmaceuticals, Inc. Previously he worked in various managerial roles of increasing importance at Integra LifeSciences Holdings Corporation from October 1993 through December 2006, most recently as Senior Vice President of Finance. While at Integra, Mr. Holtz oversaw Integra’s European operations to support the transition of acquisitions in Europe and managed all worldwide financial reporting and accounting functions. Prior to Integra, he worked for Coopers & Lybrand LLP and Cono Leasing Corporation.
Mr. Holtz received a B.S. in Business Administration with an emphasis on finance from Susquehanna University and is a Certified Public Accountant.
Carol Amelio
Vice President, General Counsel and Corporate Secretary
Ms. Amelio joined NUCRYST in February 2006 as General Counsel and Corporate Secretary. She is responsible for all of NUCRYST's legal requirements such as securities compliance and business agreement preparation and negotiation.
Prior to joining NUCRYST, Ms. Amelio served as legal counsel for The Westaim Corporation and worked extensively with NUCRYST. She supported NUCRYST's legal needs associated with meeting its corporate objectives including the preparation and negotiation of joint development, licensing, research and development, and clinical study agreements. Prior to Westaim, she held senior legal and management positions with TELUS Communications.
Ms. Amelio earned a Bachelor of Commerce with distinction and a law degree from the University of Alberta.
David C. McDowell
Vice President, Manufacturing Operations
Mr. McDowell joined NUCRYST in July of 2005 to lead the company's sales, supply and new product development effort in the burn and wound care markets. He oversees NUCRYST's quality, engineering, manufacturing, medical coatings research and wound care product development. He brings more than 25 years of management experience in the pharmaceutical, medical device and consumer packaged goods industry, both domestic and international.
Prior to joining NUCRYST, Mr. McDowell served in senior positions with Novartis, GlaxoSmithKline and Sterling Winthrop. Most recently, he held the position of General Manager Sterile Manufacturing, Head Lens Care Products Global Supply with CIBA Vision, a Novartis company, where he was responsible for global manufacturing and supply of lens care and eye care products.
Mr. McDowell is based at NUCRYST's facility in Fort Saskatchewan, Alberta, Canada. He earned a BASC in Industrial Engineering from the University of Toronto.
|
